Century Therapeutics (IPSC) Total Non-Current Liabilities (2024 - 2026)
Century Therapeutics (IPSC) posted quarterly Total Non-Current Liabilities of $59.9 million for Q1 2026, down 10.2% year-over-year from $66.7 million in Q1 2025, and down 1.87% quarter-over-quarter from $61.0 million in Q4 2025.
Century Therapeutics (IPSC) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Total Non-Current Liabilities for 3 consecutive years, with $59.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 10.2% year-over-year to $59.9 million; the TTM figure through Mar 2026 stood at $59.9 million (down 10.2% YoY), while the FY2025 annual figure was $61.0 million, down 66.68% from the prior year.
- Total Non-Current Liabilities fell to $59.9 million in Q1 2026 per IPSC's latest filing, from $61.0 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $185.0 million in Q2 2024 and bottomed at $59.2 million in Q3 2025.
- Historically, Total Non-Current Liabilities has averaged $115.0 million across 3 years, with a median of $66.7 million in 2025.
- Annual changes were most pronounced in 2025 — Total Non-Current Liabilities sank 67.79% — and 2026, when it slipped 10.2%.
- Century Therapeutics' Total Non-Current Liabilities stood at $183.1 million in 2024, then sank by 66.68% to $61.0 million in 2025, then dropped by 1.87% to $59.9 million in 2026.
- Business Quant data shows IPSC's Total Non-Current Liabilities at $59.9 million in Q1 2026, $61.0 million in Q4 2025, and $59.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 40.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.53 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.88 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.32 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.17 Bn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 54.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.00 Mn |
| Mar 31, 2026 | 59.87 Mn |
| Dec 31, 2025 | 61.01 Mn |
| Sep 30, 2025 | 59.25 Mn |
| Jun 30, 2025 | 65.91 Mn |
| Mar 31, 2025 | 66.67 Mn |
| Dec 31, 2024 | 183.12 Mn |
| Sep 30, 2024 | 183.95 Mn |
| Jun 30, 2024 | 185.03 Mn |
| Mar 31, 2024 | 170.60 Mn |